Seaweed Polyphenol Antioxidant Extract System and Method
Summary
The USPTO published patent application US20260091326A1 by inventor Sabrena Mackenzie, disclosing a process for producing a high-quality polyphenol-containing antioxidant extract from seaweed biomass. The process yields residual biomass available for alginate and fucoidan production. The application (No. 19110368) was filed September 8, 2023 and classified under CPC codes B01D 11/0288 and A61K 36/03.
What changed
The USPTO published patent application US20260091326A1 on April 2, 2026, disclosing an extraction system and method for producing polyphenol-containing antioxidant extracts from seaweed biomass. Inventor Sabrena Mackenzie developed a process yielding both a high-quality antioxidant extract and residual biomass suitable for alginate and fucoidan production. The application is classified under CPC codes B01D 11/0288, A61K 36/03, and related A61K subclasses, indicating pharmaceutical and separation process applications.
This publication does not create compliance obligations. Companies in the pharmaceutical, nutraceutical, food, and cosmetics sectors involved in antioxidant formulations or seaweed processing should note this published application for potential implications on extraction technology and biomass utilization practices. No immediate regulatory action is required.
Archived snapshot
Apr 3, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
EXTRACTION SYSTEM AND METHOD
Application US20260091326A1 Kind: A1 Apr 02, 2026
Inventors
Sabrena Mackenzie
Abstract
A process for producing a high quality polyphenol-containing antioxidant extract from a seaweed biomass that yields a residual biomass available for alginate and fucoidan production.
CPC Classifications
B01D 11/0288 A61K 36/03 B01D 11/0257 A61K 2236/15 A61K 2236/37 A61K 2236/53
Filing Date
2023-09-08
Application No.
19110368
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.